# Cancer drug response prediction on PRISM (aggregated train val test)

Source: [Cancer drug response prediction on PRISM (aggregated train val test)](<https://www.sota2.com/research/sota/cancer-drug-response-prediction-on-prism-aggregated-train-val-test>)

Collection index: [llms.txt](<https://www.sota2.com/research/llms.txt>)

Data updated: 2026-07-02T09:48:32.881Z

Evaluation of models performing Cancer Drug Response Prediction using the aggregated train, validation, and test splits of the PRISM dataset.

A research result applies to its stated dataset, split, metric and evaluation configuration. Compare like-for-like settings, preserve the metric's unit and direction, and distinguish paper-reported results from independent reproduction. The best result recorded here is not a claim of exhaustive, current global coverage.

| Scope | Recorded value |
| --- | --- |
| Task | Cancer drug response prediction |
| Dataset (including any stated split) | PRISM (aggregated train val test) |
| Metric | Mean Robustness |
| Unit | SCALAR |
| Direction | Higher is better |
| Results loaded | 2 of 2 |
| Coverage | All results currently returned for this benchmark |

Evaluation settings may differ between results. The original papers and recorded configurations are needed to establish comparability. A shared metric name alone does not establish an identical protocol.

## Metrics

- [Mean Robustness](<https://www.sota2.com/research/sota/cancer-drug-response-prediction-on-prism-aggregated-train-val-test.md?metric=Mean%20Robustness>): Higher is better; unit: SCALAR.

- [Enriched Pathways per Drug](<https://www.sota2.com/research/sota/cancer-drug-response-prediction-on-prism-aggregated-train-val-test.md?metric=Enriched%20Pathways%20per%20Drug>): Higher is better; unit: SCALAR.

- [Drugs with Enrichment](<https://www.sota2.com/research/sota/cancer-drug-response-prediction-on-prism-aggregated-train-val-test.md?metric=Drugs%20with%20Enrichment>): Higher is better; unit: PERCENT.

## Recorded results

| Method | Mean Robustness | Result date | Report paper |
| --- | --- | --- | --- |
| ILLUME+ | 0.3058 | Not recorded | 6a45f094dc71372d7795a32d |
| SHAP | 0.251 | Not recorded | 6a45f094dc71372d7795a32d |

### ILLUME+

Mean Robustness: 0.3058. Result ID: 6a4633ed60b88bb339865dd5.

[Reporting paper](<https://www.sota2.com/research/paper/6a45f094dc71372d7795a32d.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a45f094dc71372d7795a32d.md>)

Recorded evaluation configuration: Not recorded. This record does not assert independent reproduction.

### SHAP

Mean Robustness: 0.251. Result ID: 6a4633ed60b88bb339865dd6.

[Reporting paper](<https://www.sota2.com/research/paper/6a45f094dc71372d7795a32d.md>)

[Method origin paper](<https://www.sota2.com/research/paper/68fa63d01e209131cea00e17.md>)

Recorded evaluation configuration: Not recorded. This record does not assert independent reproduction.

Page 1 of 1. This is an index page, not the full collection.
